Maryland Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Buy
+698
New +$239K 0.08% 78
2025
Q4
$228K Hold
696
0.08% 79
2025
Q3
$196K Sell
696
-36
-5% -$10.4K 0.07% 82
2025
Q2
$204K Buy
732
+36
+5% +$10.2K 0.08% 78
2025
Q1
$217K Hold
696
0.1% 72
2024
Q4
$181K Hold
696
0.08% 75
2024
Q3
$224K Hold
696
0.11% 68
2024
Q2
$217K Hold
696
0.12% 65
2024
Q1
$198K Hold
696
0.12% 69
2023
Q4
$200K Hold
696
0.13% 67
2023
Q3
$187K Hold
696
0.14% 66
2023
Q2
$155K Hold
696
0.12% 69
2023
Q1
$168K Hold
696
0.15% 68
2022
Q4
$183K Hold
696
0.17% 64
2022
Q3
$157K Hold
696
0.16% 62
2022
Q2
$169K Hold
696
0.18% 57
2022
Q1
$168K Hold
696
0.15% 56
2021
Q4
$157K Buy
+696
New +$147K 0.13% 58

Other funds holding AMGN

Maryland Capital Advisors's AMGN Position: Q2 2026 in Review

Maryland Capital Advisors opened a new position in Amgen (AMGN) in Q2 2026: 698 shares worth $253K. The stake represents 0.08% of the portfolio and ranks #78 among its holdings. This is a return to the name: Maryland Capital Advisors previously reported a position in AMGN as recently as Q4 2025.

Maryland Capital Advisors first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 1,585 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Maryland Capital Advisors held 698 shares of Amgen worth $253K as of Q2 2026.
  • Amgen was a new Maryland Capital Advisors position in Q2 2026.
  • Amgen made up 0.08% of Maryland Capital Advisors's portfolio in Q2 2026, its #78 holding.
  • Maryland Capital Advisors first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 1,585 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Maryland Capital Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.